Insurance-supported integrative oncology symptom management program benefits cancer patients

https://www.news-medical.net/news/20260711/Insurance-supported-integrative-oncology-symptom-management-program-benefits-cancer-patients.aspx A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea, and fatigue. The findings highlight a scalable model with potential for delivering future integrative therapies within routine oncology care. The findings from this study were recently published in JCO Oncology Practice.

Harvard University hosts the world's largest conference dedicated to longevity biotechnology

https://www.news-medical.net/news/20260711/Harvard-University-hosts-the-worlds-largest-conference-dedicated-to-longevity-biotechnology.aspx The 13th Aging Research & Drug Discovery (ARDD) Meeting, the world's largest conference dedicated to longevity biotechnology, will take place from October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University. Marking the high-profile launch of Boston Longevity Week, this landmark event is officially organized by Insilico Medicine, which also anchors the conference as a Tier 1 sponsor alongside Eli Lilly.

Open source tool automates data reanalysis to detect rare diseases

https://www.news-medical.net/news/20260624/Open-source-tool-automates-data-reanalysis-to-detect-rare-diseases.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses. And the tool's ability to frequently and automatically reexamine stored DNA data will ensure more timely answers for hundreds of families. World-leading research has found Talos, created and validated by researchers in Australia and the US, was able to find rare disease diagnoses at scale, quickly, and at low cost, addressing a major bottleneck.

Experimental drug shields nerve cells from damage caused by ALS +++++++

Experimental drug shields nerve cells from damage caused by ALS https://www.news-medical.net/news/20260703/Experimental-drug-shields-nerve-cells-from-damage-caused-by-ALS.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Experimental drug shields nerve cells from damage caused by ALSAmyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket Challenge. Millions of people participated in the challenge, drenching themselves in ice cold water to bring visibility to this devastating neurodegenerative disease and generate charitable donations for research. LMU researchers discover new genetic cause of Crohn's disease https://www.news-medical.net/news/20260624/LMU-researchers-discover-new-genetic-cause-of-Crohns-disease.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 LMU researchers discover new genetic cause of Crohn's diseaseA team led by LMU physician Daniel Kotlarz has identified a previously unknown genetic cause of Crohn's disease. UC San Diego study reveals genetic causes of rare neuromuscular disorders https://www.news-medical.net/news/20260701/UC-San-Diego-study-reveals-genetic-causes-of-rare-neuromuscular-disorders.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 UC San Diego study reveals genetic causes of rare neuromuscular disordersScientists at the University of California San Diego have uncovered how genetic mutations cause a rare group of inherited neuromuscular disorders and identified promising new strategies to correct them, including a potential new use for an existing antidepressant. Scientists uncover immune mechanisms driving rare gastrointestinal disorder https://www.news-medical.net/news/20260626/Scientists-uncover-immune-mechanisms-driving-rare-gastrointestinal-disorder.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Scientists uncover immune mechanisms driving rare gastrointestinal disorderA collaborative team led by Dr. Jingnan Li and Dr. Ji Li at Peking Union Medical College Hospital, together with Associate Professor Xiaohuan Guo at Tsinghua University and Academician Ye-Guang Chen at Tsinghua University School of Life Sciences, published a study in Volume 2, article number 28 of the journal Immunity & Inflammation on June 17, 2026. AI image-based risk scores enable dynamic breast cancer assessment https://www.news-medical.net/news/20260623/AI-image-based-risk-scores-enable-dynamic-breast-cancer-assessment.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 AI image-based risk scores enable dynamic breast cancer assessmentUsing artificial intelligence (AI), researchers found that image-based risk scores for breast cancer derived from screening mammograms evolve over time and differ between women who develop cancer and those who do not, opening the door to a new era of dynamic breast cancer risk assessment. Study potential new therapeutic strategy for patients with ATRX-mutant gliomas https://www.news-medical.net/news/20260701/Study-potential-new-therapeutic-strategy-for-patients-with-ATRX-mutant-gliomas.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Study potential new therapeutic strategy for patients with ATRX-mutant gliomasA new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas. New diagnostic tool bypasses blood-brain barrier to detect autism early https://www.news-medical.net/news/20260630/New-diagnostic-tool-bypasses-blood-brain-barrier-to-detect-autism-early.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 New diagnostic tool bypasses blood-brain barrier to detect autism earlyA study published in NeuroMarkers showed that a nanosensor can measure nitric oxide (NO) from patient-derived stem cells to distinguish autism spectrum disorder (ASD) from intellectual disability (ID), even when both conditions share the exact same genetic mutation.

Researchers use AI to predict rare cancer immunotherapy responses

https://www.news-medical.net/news/20260630/Researchers-use-AI-to-predict-rare-cancer-immunotherapy-responses.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer. Led by Aung Naing, M.D., professor of Investigational Cancer Therapeutics, this analysis builds on recently published research that identified features in the tumor microenvironment that were predictive of immunotherapy response in patients with rare cancers, even in those who did not have known markers of immunotherapy response.

Study provides new insights into biological processes linked to Huntington’s disease

https://www.news-medical.net/news/20260706/Study-provides-new-insights-into-biological-processes-linked-to-Huntingtone28099s-disease.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the stage of Huntington's disease. This discovery opens the door both to the use of new biomarkers for monitoring the disease and to the development of treatments for a condition for which no therapeutic options are currently available.

Scientists discover 70 existing drugs that block deadly hantavirus infections

A massive drug-repurposing screen of over 5,000 compounds has uncovered unexpected antiviral powers in common antibiotics, offering a fast-tracked pipeline to treat life-threatening orthohantavirus infections. https://www.news-medical.net/news/20260628/Scientists-discover-70-existing-drugs-that-block-deadly-hantavirus-infections.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 In a recent study published in the journal Scientific Reports, researchers conducted a high-throughput phenotypic drug screening using live Puumala virus (PUUV) to fast-track therapeutic discovery against disease caused by orthohantaviruses.